Where does Simplivia Healthcare Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Simplivia Healthcare Ltd. ranks #37,552 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Simplivia Healthcare Ltd. hold?

Simplivia Healthcare Ltd. holds 7 US utility patents granted between 2020 and 2023, spanning 3 technology areas.

What is Simplivia Healthcare Ltd.'s Innovation Score?

Simplivia Healthcare Ltd. has an Innovation Score of 31.0 out of 100 (36th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Simplivia Healthcare Ltd.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Simplivia Healthcare Ltd..

What does claim depth mean for Simplivia Healthcare Ltd.'s patents?

Simplivia Healthcare Ltd.'s patents average 14.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Simplivia Healthcare Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Simplivia Healthcare Ltd.

Q: What technology areas does Simplivia Healthcare Ltd. focus on?

Simplivia Healthcare Ltd.'s top technology area is A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle) with 5 patents, ranking #204 of 903 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

USPTO PatentsView assignee record - 7 granted patents across 3 technology areas, recorded in grant years 2020–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Simplivia ranks #37,552 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 3 technology areas.

#37,552
of 49,997 US assignees by volume: 36th percentile
by Innovation Score (31.0/100): 14.7
avg claims per patent

USPTO PatentsView assignee plate

Corpus R37552 · Foreign Corporation #37,552 · 7 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 7 grants
LOWER-Q #37,552/49,997
PHOTO-FINISH Silicon Biosystems…
CPC-NARROW A61J · 3 areas
INNOV-THIN 31.0/100
CLAIMS-RICH 14.7 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2020–2023 · 4y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Silicon Biosystems S.P.A. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Simplivia’s 31.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (23%) Velocity 8.9 pts (29%) Breadth 6.1 pts (20%) Claim depth 8.8 pts (28%)

Qualcomm Incorporated · highest

85
Simplivia Healthcare · this assignee

31
3D Lighting… · lowest

7

What this shows Simplivia's Innovation Score is 31.0/100 (36th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Simplivia?

Each dot is one of Simplivia’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Simplivia’s own 14.7 claims/patent is ABOVE the 9.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Simplivia vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Simplivia's grants concentrate

Simplivia Healthcare Ltd. is a focused PatentsView assignee: 3 CPC subclasses with 71.4% of grants classified under A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ). Peak complete grant year is 2022 (3 grants) versus a trough of 1 in 2021. By volume, Simplivia sits between Silicon Biosystems S.P.A. and Singularity AG.

Simplivia's three-year grant acceleration

Simplivia Healthcare Ltd. shows 4 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Silicon Biosystem…

7
Silmach

7
Silver Cross (IP)

7
Simplicity Works…

7
Simpson Biotech

7
SIMU

7
Simur

7
Singularity

7
Simplivia Healthc… ◀

7

What this shows Simplivia holds 7 patents at rank #37,422, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Simplivia

By rank, the assignees closest to #37,422 in granted patent volume.

Leaders in A61J (Containers Specially Adapted FOR Medical OR Pharmaceutica…)

Other assignees with the most granted patents in Simplivia's primary technology class.

Simplivia's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 36th percentile higher than 36% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Simplivia Healthcare Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	2	28.6%
2021	1	14.3%
2022	3	42.9%
2023	1	14.3%

Which technologies does Simplivia Healthcare Ltd. patent most?

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 5

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 5

G21F - Protection Against X-radiation, Gamma Radiation, Corpuscular Radiation OR Particle BOMBARDMENT; Treating Radioactively Contaminated MATERIAL; Decontamination Arrangements Therefor 1

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Simplivia Healthcare Ltd.'s patent record in context - here's where to go next.

Simplivia Healthcare Ltd.'s lead technology class is A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ), 71.4% of its portfolio - see every assignee active in that class. Explore A61J
Ranked #37,552 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Simplivia Healthcare Ltd. against Silicon Biosystems S.P.A., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 31.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.